TFRC and diabetes mellitus: Complementary to findings by Ghanim et al.15, who reported an increase in transferrin receptor-1 mRNA expression in patients with diabetes on dapagliflozin, and to observations from DAPA-HF20, we found that sTfR levels increased with empagliflozin.